Extinction coefficient measurement of NagS.

Extinction coefficient measurement of NagS.

<p>(<b>a</b>) This standard curve of GlcNAc-6P was obtained by plotting the concentration of GlcNAc-6P (1, 1.67, 2.67, 3.33, 4, and 5 mM) with the corresponding peak area detected in the LC–MS spectrum. (<b>b</b>) Area of the GlcNAc-6P peak after the reaction catalyzed...

Saved in:

書目詳細資料
主要作者:	Chao Li (145513) (author)
其他作者:	Mia Urem (22683580) (author), Ioli Kotsogianni (9930187) (author), Josephine Lau (20442343) (author), Chao Du (288036) (author), Somayah S. Elsayed (9192571) (author), Nathaniel I. Martin (847378) (author), Iain W. McNae (840777) (author), Patrick Voskamp (2311429) (author), Christoph Mayer (57204) (author), Sébastien Rigali (724082) (author), Navraj Pannu (10163763) (author), Jan Pieter Abrahams (1429531) (author), Lennart Schada von Borzyskowski (22683583) (author), Gilles P. van Wezel (7838948) (author)
出版:	2025
主題:	Biochemistry Microbiology Ecology Developmental Biology Inorganic Chemistry Biological Sciences not elsewhere classified controls nutrient signaling also revealed 6 highlighted key residues glcnac sensing requires toxicity pathway dependent 6p deacetylase naga novel glcnac 6 key role substrate glcnac novel enzyme work uncovers wall leads unprecedented reaction substrate mycelium structural analogue streptomycetaceae </ streptomyces </ revolves around promiscuous activity nature ’ n </ multicellular lifestyle metabolic checkpoint medicine makers lytic dismantling landmark event hyphal cell highly conserved growth media function analysis clinical antibiotics central metabolism catalytic inhibitor antibiotic production active site >- acetylglucosamine 6p dehydratase
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Kinetics of <i>S. coelicolor</i> NagA and the product identification of NagS-NagA catalysis.
由: Chao Li (145513)
出版: (2025)

Analysis of the binding site of NagS and activity of NagS mutants.
由: Chao Li (145513)
出版: (2025)

Roles of NagS and NagA in GlcNAc toxicity.
由: Chao Li (145513)
出版: (2025)

Kinetic parameters for <i>S. coelicolor</i> NagS and NagA.
由: Chao Li (145513)
出版: (2025)

Crystal structure of NagS.
由: Chao Li (145513)
出版: (2025)

Phylogenomic analysis of NagS.
由: Chao Li (145513)
出版: (2025)

Kinetics of NagS variants.
由: Chao Li (145513)
出版: (2025)

Catalytic substrates of NagS.
由: Chao Li (145513)
出版: (2025)

Function determination and kinetics of NagS.
由: Chao Li (145513)
出版: (2025)

Substrate binding pocket and the movable loop of NagS.
由: Chao Li (145513)
出版: (2025)

Activity test of NagS homologs in vitro and in vivo.
由: Chao Li (145513)
出版: (2025)

Size-exclusion chromatography analysis of purified NagS.
由: Chao Li (145513)
出版: (2025)

Model for the metabolic control of development by GlcNAc and NagS.
由: Chao Li (145513)
出版: (2025)

Inhibitory effect of 6-phosphogluconate (6-PG) on NagS.
由: Chao Li (145513)
出版: (2025)

NagS is a conserved protein amongst Streptomycete organisms.
由: Chao Li (145513)
出版: (2025)

Inhibition of siderophore production by GlcNAc requires NagS.
由: Chao Li (145513)
出版: (2025)

NagS is a novel GlcNAc-6P dehydratase.
由: Chao Li (145513)
出版: (2025)

New function of <i>S. coelicolor</i> NagA and an updated amino sugar metabolic pathway.
由: Chao Li (145513)
出版: (2025)

Data underlying figures.
由: Chao Li (145513)
出版: (2025)

Spectroscopic data of compound 1.
由: Chao Li (145513)
出版: (2025)

Metabolic pathway of aminosugar in <i>Streptomyces.</i>
由: Chao Li (145513)
出版: (2025)

Image 1_Vitamin D supplementation and its impact on leptin and interleukin-6 in women following religious intermittent fasting: a controlled study.png
由: Spyridon N. Karras (22080581)
出版: (2025)

Table 1_Comparative analysis of the therapeutic effect of antibiotic bone cement on Wagner grade 3 or 4 diabetic foot ulcer in heel and non-heel areas: a retrospective cohort study.docx
由: Yang Jian (5274260)
出版: (2025)

Spearman correlation analysis between gut microbial taxa and circulating metabolites, detailing correlation coefficients, significance values, and taxon–metabolite pairings indicative of microbiome–host metabolic interactions.
由: Ji-Xin Zhao (22056386)
出版: (2025)

Medication-inclusive multivariable logistic regression for MAFLD.
由: Zienab M. Saad (22676502)
出版: (2025)

Multivariable logistic regression models for MAFLD predictors.
由: Zienab M. Saad (22676502)
出版: (2025)

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64).
由: Zienab M. Saad (22676502)
出版: (2025)

Liver Stiffness and Fibrosis Grading by MAFLD Status.
由: Zienab M. Saad (22676502)
出版: (2025)

Comparison of Non-invasive Liver Fibrosis Scores.
由: Zienab M. Saad (22676502)
出版: (2025)

Demographic and Clinical Characteristics of Study Participants.
由: Zienab M. Saad (22676502)
出版: (2025)

Proposed pathophysiological crosstalk between MAFLD and CKD.
由: Zienab M. Saad (22676502)
出版: (2025)

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients.
由: Zienab M. Saad (22676502)
出版: (2025)

Stratification of Liver Stiffness according to eGFR in the MAFLD group.
由: Zienab M. Saad (22676502)
出版: (2025)

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups.
由: Zienab M. Saad (22676502)
出版: (2025)

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black).
由: Zienab M. Saad (22676502)
出版: (2025)

eGFR in the study participants.
由: Zienab M. Saad (22676502)
出版: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years).
由: Zienab M. Saad (22676502)
出版: (2025)

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years).
由: Zienab M. Saad (22676502)
出版: (2025)

2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years).
由: Zienab M. Saad (22676502)
出版: (2025)

<b>Multi-dimensional Resource Synergy and Coded Computation Theory for 6G Satellite-Terrestrial Integrated Networks</b>
由: f y (22066025)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_72hrd784r80tc1tjkpcomlafg6